Unnati Pharmax

Taclistat Ointment 0.03%
Composition: Tacrolimus Ointment IP 0.03% w/w
International Trade Name: Taclistat® (Topical Immunomodulator)

Taclistat Ointment 0.03% is a high-quality topical formulation containing Tacrolimus, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, Taclistat Ointment is designed for effective management of inflammatory dermatological conditions, supporting dermatology treatment programs globally.

Tacrolimus is a calcineurin inhibitor that works by modulating T-cell activation and suppressing inflammatory cytokines, thereby reducing redness, itching, and inflammation in affected skin areas. The ointment formulation ensures enhanced skin penetration, localized action, and patient compliance, making it suitable for long-term therapy under medical supervision.

Taclistat Ointment 0.03% is primarily indicated for the topical treatment of moderate to severe atopic dermatitis (eczema) in patients for whom conventional therapies such as topical corticosteroids are inappropriate or ineffective. It is also widely used in dermatology clinics and hospitals for sensitive skin areas, such as the face, neck, and skin folds.

Taclistat Ointment, Tacrolimus 0.03% topical ointment, immunomodulator cream, atopic dermatitis therapy, anti-inflammatory dermatology ointment, sensitive skin eczema treatment, dermatology exporter India, and pharmaceutical manufacturer India.

Taclistat Ointment 0.03% is manufactured under strict GMP and quality assurance standards, ensuring consistent efficacy, safety, and product stability. The ointment is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Tretin 0.05% Cream
Composition: Tretinoin 0.05% w/w
International Trade Name: Tretin

Tretin 0.05% Cream is a high-quality topical retinoid formulation containing Tretinoin 0.05%, designed for the effective management of acne vulgaris and photoaged skin. Manufactured in WHO-GMP certified facilities, Tretin Cream is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial cell turnover, preventing comedone formation, and promoting skin renewal. Tretin 0.05% Cream helps reduce both inflammatory and non-inflammatory acne lesions, improves skin texture, and minimizes fine lines, hyperpigmentation, and sun-induced skin damage.

Tretin 0.05% Cream is primarily indicated for the topical treatment of mild to moderate acne vulgaris, particularly in patients requiring advanced retinoid therapy. It is also widely used in dermatological regimens for photoaging, skin rejuvenation, and pigmentation management. The cream formulation ensures smooth application, better skin penetration, and enhanced patient compliance.

Tretin 0.05% Cream, Tretinoin topical cream, anti-acne retinoid therapy, skin renewal cream, photoaging treatment, dermatology cream, pharmaceutical exporter India, and dermatology manufacturer India.

Tretin 0.05% Cream is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

Tretin 0.025% Cream
Composition: Tretinoin 0.025% w/w
International Trade Name: Tretin

Tretin 0.025% Cream is a high-quality topical retinoid formulation containing Tretinoin 0.025%, designed for the management of acne vulgaris and early signs of photoaging. Manufactured in WHO-GMP certified facilities, Tretin Cream is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial cell turnover, preventing comedone formation, and promoting skin renewal. Tretin 0.025% Cream helps reduce mild inflammatory and non-inflammatory acne lesions, improves skin texture, and supports the early treatment of fine lines, uneven pigmentation, and sun-induced skin damage.

Tretin 0.025% Cream is primarily indicated for the topical treatment of mild to moderate acne vulgaris, as well as in dermatological regimens for skin rejuvenation and early photoaging. Its cream formulation ensures smooth application, gentle action on sensitive skin, and enhanced patient compliance.

Tretin 0.025% Cream, Tretinoin topical cream, low-strength anti-acne retinoid therapy, skin renewal cream, photoaging management, dermatology cream, pharmaceutical exporter India, and dermatology manufacturer India.

Tretin 0.025% Cream is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

Melamet Cream
Composition: Hydroquinone 2% w/w + Tretinoin 0.05% w/w + Mometasone Furoate 0.1% w/w
International Trade Name: Melamet

Melamet Cream is a high-quality combination topical formulation containing Hydroquinone, Tretinoin, and Mometasone Furoate, designed for the effective management of hyperpigmentation, melasma, and other pigmentary disorders. Manufactured in WHO-GMP certified facilities, Melamet Cream is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Hydroquinone acts as a skin-lightening agent by inhibiting melanin synthesis, Tretinoin, a vitamin A derivative, promotes cell turnover and enhances penetration of active ingredients, while Mometasone Furoate, a potent corticosteroid, helps reduce inflammation and irritation. The combination ensures rapid, visible improvement in skin tone, pigmentation, and texture.

Melamet Cream is primarily indicated for the topical treatment of melasma, chloasma, post-inflammatory hyperpigmentation, and other corticosteroid-responsive pigmentary disorders. Its cream-based formulation allows easy application, optimal absorption, and enhanced patient compliance.

Melamet Cream, Hydroquinone + Tretinoin + Mometasone topical cream, depigmentation therapy, anti-melasma treatment, skin tone improvement cream, dermatology pigmentary disorder management, pharmaceutical exporter India, and dermatology manufacturer India.

Melamet Cream is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

Clindakem A Gel
Composition: Adapalene 0.1% w/w + Clindamycin Phosphate 1% w/w
International Trade Name: Clindakem A

Clindakem A Gel is a high-quality combination topical gel containing Adapalene (a retinoid) and Clindamycin Phosphate (a topical antibiotic), designed for the effective management of acne vulgaris. Manufactured in WHO-GMP certified facilities, Clindakem A Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Adapalene works by normalizing follicular epithelial cell turnover and preventing comedone formation, while Clindamycin Phosphate reduces bacterial colonization and inflammation caused by Cutibacterium acnes. The combination provides dual action therapy, targeting both the underlying causes of acne and inflammatory lesions for faster and more effective results.

Clindakem A Gel is primarily indicated for the topical treatment of mild to moderate acne vulgaris, including papules, pustules, and comedonal acne. Its gel-based formulation ensures easy application, rapid absorption, and enhanced patient compliance.

Clindakem A Gel, Adapalene + Clindamycin topical gel, dual-action anti-acne therapy, retinoid-antibiotic combination, acne lesion management, dermatology gel, pharmaceutical exporter India, and dermatology manufacturer India.

Clindakem A Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Skin Fine Iso-20 Capsules
Composition: Isotretinoin 20mg Capsules
International Trade Name: Accutane®

Skin Fine Iso-20 is a high-quality Isotretinoin 20mg capsule formulation, a retinoid indicated for the treatment of severe recalcitrant nodular acne and other dermatological conditions resistant to conventional therapy. Manufactured in WHO-GMP certified facilities, Skin Fine Iso-20 Capsules are supplied by trusted pharmaceutical exporters from India to support global dermatology treatment programs.

Isotretinoin works by reducing sebaceous gland activity, normalizing keratinization, and exhibiting anti-inflammatory effects, thereby targeting the root causes of severe acne. Skin Fine Iso-20 helps in significantly reducing acne lesions, preventing scarring, and improving overall skin health in patients with severe or treatment-resistant acne.

Skin Fine Iso-20 Capsules are primarily indicated for the management of severe nodular acne, cystic acne, and other dermatological conditions as prescribed by healthcare professionals. They are suitable for adult patients under strict medical supervision, with appropriate monitoring due to potential side effects and contraindications.

Skin Fine Iso-20 Isotretinoin Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, dermatology clinics, retail pharmacies, and international pharmaceutical distributors.

GARYCLAV-LB-625 Tablets
Composition: Amoxicillin 500 mg + Potassium Clavulanate 125 mg + Lactic Acid Bacillus
Dosage Form: Film-Coated Tablets
International Trade Name: GARYCLAV-LB-625

GARYCLAV-LB-625 Tablets are a high-quality broad-spectrum antibiotic formulation combining Amoxicillin and Potassium Clavulanate, supplemented with Lactic Acid Bacillus to support gut health during antibiotic therapy. Manufactured in WHO-GMP certified facilities, GARYCLAV-LB-625 is supplied by trusted pharmaceutical manufacturers and exporters from India to support effective antibacterial treatment programs worldwide.

Amoxicillin is a penicillin-class antibiotic effective against a wide range of gram-positive and gram-negative bacteria, while Potassium Clavulanate acts as a beta-lactamase inhibitor, protecting Amoxicillin from enzymatic degradation and thereby enhancing its antibacterial spectrum. The addition of Lactic Acid Bacillus helps maintain normal intestinal microflora, reducing the risk of antibiotic-associated diarrhea.

GARYCLAV-LB-625 Tablets are primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, ENT infections, dental infections, and other susceptible bacterial infections, as prescribed by healthcare professionals.

GARYCLAV-LB-625 Tablets, Amoxicillin Clavulanate tablets with probiotic, broad-spectrum antibiotic therapy, LB combination tablets, antibacterial tablets exporter India, and pharmaceutical manufacturer India.

GARYCLAV-LB-625 Tablets are manufactured under stringent GMP and quality control standards, ensuring consistent potency, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, clinics, pharmacies, government healthcare programs, and international pharmaceutical distributors.

A-Ret Gel 0.025%
Composition: Tretinoin Gel 0.025% w/w
International Trade Name: Tretinoin (Topical Retinoid)

A-Ret Gel 0.025% is a clinically proven topical retinoid gel containing Tretinoin 0.025%, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, A-Ret Gel 0.025% meets global dermatology treatment standards for the management of acne and photoaged skin.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial differentiation, promoting cell turnover, and preventing comedone formation. The 0.025% strength offers gentle yet effective therapy, making it ideal for patients initiating retinoid treatment or with sensitive skin. A-Ret Gel 0.025% helps reduce acne lesions, improves skin texture, and minimizes early signs of photoaging such as fine lines and pigmentation.

A-Ret Gel Tretinoin 0.025% is primarily indicated for the topical treatment of mild to moderate acne vulgaris. It is also widely prescribed in dermatological regimens for skin rejuvenation, early photoaging, and prevention of comedonal acne under medical supervision.

A-Ret Gel 0.025%, Tretinoin topical gel, mild retinoid therapy, anti-acne dermatology gel, vitamin A derivative, skin renewal therapy, acne management, dermatology exporter India, and pharmaceutical manufacturer India.

A-Ret Gel Tretinoin 0.025% is manufactured under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The gel is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

IMXIA F 5% Topical Solution
Composition: Minoxidil 5% w/v + Finasteride 0.1% w/v
International Trade Name: IMXIA F

IMXIA F 5% is a high-quality combination topical solution containing Minoxidil 5% and Finasteride 0.1%, designed for the management of androgenetic alopecia (male pattern hair loss). Manufactured in WHO-GMP certified facilities, IMXIA F is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced hair restoration treatment programs globally.

Minoxidil is a potent vasodilator that stimulates hair follicle activity, prolongs the anagen phase, and promotes hair regrowth, while Finasteride is a 5-alpha-reductase inhibitor that reduces DHT levels, preventing further hair loss. The combination ensures a dual-action approach, targeting both hair regrowth stimulation and reduction of hair follicle miniaturization.

IMXIA F 5% is primarily indicated for the topical treatment of androgenetic alopecia in adult males, including thinning hair on the vertex and frontal scalp regions. Its solution-based formulation allows easy application, rapid absorption, and enhanced patient compliance.

IMXIA F 5% Topical Solution, Minoxidil + Finasteride topical solution, anti-hair loss therapy, male pattern baldness treatment, hair regrowth solution, pharmaceutical exporter India, and dermatology manufacturer India.

IMXIA F 5% is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hair restoration centers, pharmacies, government hair care programs, and international pharmaceutical distributors.

Irosis-20 Capsules
Composition: Isotretinoin 20 mg
International Trade Name: Irosis-20

Irosis-20 Capsules are a high-quality oral retinoid formulation containing Isotretinoin 20 mg, designed for the effective management of severe recalcitrant acne vulgaris. Manufactured in WHO-GMP certified facilities, Irosis-20 is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Isotretinoin is a vitamin A derivative that works by reducing sebaceous gland activity, normalizing follicular epithelial cell turnover, and exerting anti-inflammatory effects, leading to long-term reduction of acne lesions and prevention of recurrence. Irosis-20 provides a precise oral dosage for optimized therapeutic outcomes under medical supervision.

Irosis-20 Capsules are primarily indicated for the treatment of severe, nodulocystic, or treatment-resistant acne vulgaris, particularly in patients who have failed conventional therapy including topical agents and antibiotics. The capsules are formulated for high bioavailability, consistent dosing, and patient compliance.

Irosis-20, Isotretinoin oral capsules, severe acne therapy, anti-seborrheic retinoid, dermatology oral treatment, pharmaceutical exporter India, and dermatology manufacturer India.

Irosis-20 Capsules are produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Irosis-30 Capsules
Composition: Isotretinoin 30 mg
International Trade Name: Irosis-30

Irosis-30 Capsules are a high-quality oral retinoid formulation containing Isotretinoin 30 mg, designed for the effective management of severe recalcitrant acne vulgaris. Manufactured in WHO-GMP certified facilities, Irosis-30 is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Isotretinoin is a vitamin A derivative that works by reducing sebaceous gland activity, normalizing follicular epithelial cell turnover, and exerting anti-inflammatory effects, resulting in long-term reduction of acne lesions and prevention of recurrence. Irosis-30 provides a precise oral dosage for optimized therapeutic outcomes under medical supervision.

Irosis-30 Capsules are primarily indicated for the treatment of severe, nodulocystic, or treatment-resistant acne vulgaris, particularly in patients who have failed conventional therapy including topical agents and antibiotics. The capsules are formulated for high bioavailability, consistent dosing, and patient compliance.

Irosis-30, Isotretinoin oral capsules, severe acne therapy, anti-seborrheic retinoid, dermatology oral treatment, pharmaceutical exporter India, and dermatology manufacturer India.

Irosis-30 Capsules are produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Resoten-10 Capsules
Composition: Isotretinoin 10 mg
International Trade Name: Resoten-10

Resoten-10 Capsules are a high-quality oral retinoid formulation containing Isotretinoin 10 mg, designed for the effective management of moderate to severe acne vulgaris. Manufactured in WHO-GMP certified facilities, Resoten-10 is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Isotretinoin is a vitamin A derivative that works by reducing sebaceous gland activity, normalizing follicular epithelial cell turnover, and providing anti-inflammatory effects, resulting in significant reduction of acne lesions and prevention of recurrence. Resoten-10 provides precise oral dosing, allowing dermatologists to customize therapy according to patient severity and tolerance.

Resoten-10 Capsules are primarily indicated for the treatment of moderate to severe acne vulgaris, including nodulocystic acne, especially in patients who have not responded to conventional topical and systemic therapies. Its capsule formulation ensures high bioavailability, consistent dosing, and improved patient compliance.

Resoten-10, Isotretinoin oral capsules, moderate to severe acne therapy, anti-seborrheic retinoid, dermatology oral treatment, pharmaceutical exporter India, and dermatology manufacturer India.

Resoten-10 Capsules are manufactured under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Irosis-5 Capsules
Composition: Isotretinoin 5 mg
International Trade Name: Irosis-5

Irosis-5 Capsules are a high-quality oral retinoid formulation containing Isotretinoin 5 mg, designed for the management of mild to moderate acne vulgaris and for dose-adjusted therapy in severe acne cases. Manufactured in WHO-GMP certified facilities, Irosis-5 is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Isotretinoin is a vitamin A derivative that works by reducing sebaceous gland activity, normalizing follicular epithelial cell turnover, and exerting anti-inflammatory effects, leading to significant reduction in acne lesions and prevention of recurrence. The 5 mg strength allows for flexible, low-dose therapy, making it suitable for maintenance treatment or gradual dose titration under medical supervision.

Irosis-5 Capsules are primarily indicated for the treatment of mild to moderate acne vulgaris, dose-adjusted therapy for severe acne, and as part of long-term maintenance regimens to prevent relapse. The capsules are formulated for high bioavailability, consistent dosing, and patient compliance.

Irosis-5, Isotretinoin oral capsules, acne management therapy, low-dose retinoid treatment, dermatology oral treatment, pharmaceutical exporter India, and dermatology manufacturer India.

Irosis-5 Capsules are produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Acnon Gel
Composition: Tretinoin 0.05% w/w (USP Grade)
International Trade Name: Acnon Gel

Acnon Gel is a high-quality topical retinoid formulation containing Tretinoin USP, designed for the effective management of acne vulgaris and photo-damaged skin. Manufactured in WHO-GMP certified facilities, Acnon Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial cell turnover, preventing comedone formation, and promoting skin renewal. Acnon Gel helps reduce both inflammatory and non-inflammatory acne lesions, improves skin texture, and minimizes the appearance of fine lines, hyperpigmentation, and sun-induced skin damage.

Acnon Gel is primarily indicated for the topical treatment of mild to moderate acne vulgaris and can be used as part of dermatological regimens for photoaging, hyperpigmentation, and skin rejuvenation. Its gel-based formulation ensures fast absorption, non-greasy application, and enhanced patient compliance.

Acnon Gel, Tretinoin USP topical gel, anti-acne retinoid therapy, skin renewal gel, photoaging and hyperpigmentation management, dermatology gel, pharmaceutical exporter India, and skincare manufacturer India.

Acnon Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin health programs, and international pharmaceutical distributors.

Acnon Gel 0.1%
Composition: Tretinoin 0.1% w/w (USP Grade)
International Trade Name: Acnon Gel

Acnon Gel 0.1% is a high-quality topical retinoid formulation containing Tretinoin 0.1% USP, designed for the effective management of acne vulgaris and photoaged skin. Manufactured in WHO-GMP certified facilities, Acnon Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial cell turnover, preventing comedone formation, and promoting skin renewal. Acnon Gel 0.1% helps reduce inflammatory and non-inflammatory acne lesions, improves skin texture, and minimizes fine lines, hyperpigmentation, and sun-induced skin damage.

Acnon Gel 0.1% is primarily indicated for the topical treatment of moderate to severe acne vulgaris, particularly in patients requiring higher-strength retinoid therapy. It is also used in dermatological regimens for photoaging, skin rejuvenation, and hyperpigmentation management. The gel formulation ensures rapid absorption, non-greasy application, and enhanced patient compliance.

Acnon Gel 0.1%, Tretinoin USP topical gel, high-strength anti-acne retinoid therapy, skin renewal gel, photoaging treatment, dermatology gel, pharmaceutical exporter India, and dermatology manufacturer India.

Acnon Gel 0.1% is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors

TBIS 0.1% Ointment
Composition: Tacrolimus 0.1% w/w
International Trade Name: Protopic

TBIS 0.1% Ointment is a high-quality topical immunomodulatory formulation containing Tacrolimus 0.1%, designed for the management of moderate to severe atopic dermatitis and other corticosteroid-responsive dermatological conditions. Manufactured in WHO-GMP certified facilities, TBIS Ointment is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Tacrolimus is a calcineurin inhibitor that works by inhibiting T-cell activation and suppressing pro-inflammatory cytokine release, effectively reducing redness, inflammation, and itching associated with chronic skin disorders. TBIS Ointment provides a non-greasy, smooth formulation, allowing rapid absorption and targeted action on affected areas while avoiding the side effects associated with long-term corticosteroid use.

TBIS 0.1% Ointment is primarily indicated for the topical treatment of moderate to severe atopic dermatitis in adults and children above 2 years of age, particularly in cases where conventional corticosteroid therapy is insufficient or not recommended. It may also be used for other immune-mediated dermatological conditions under specialist supervision.

TBIS Ointment, Tacrolimus topical ointment, immunomodulatory dermatology therapy, anti-inflammatory skin treatment, atopic dermatitis management, pharmaceutical exporter India, and dermatology manufacturer India.

TBIS 0.1% Ointment is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

A-RET 0.01% Gel
Composition: Tretinoin 0.01% w/w (USP Grade)
International Trade Name: A-RET

A-RET 0.01% Gel is a high-quality topical retinoid formulation containing Tretinoin 0.01%, designed for the gentle management of acne vulgaris and early signs of photoaging. Manufactured in WHO-GMP certified facilities, A-RET Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial cell turnover, preventing comedone formation, and promoting skin renewal. At the 0.01% strength, A-RET Gel is suitable for sensitive skin or patients starting retinoid therapy, providing gradual improvement in acne lesions, fine lines, and hyperpigmentation with minimal irritation.

A-RET 0.01% Gel is primarily indicated for the topical treatment of mild acne vulgaris, early photoaging, and hyperpigmentation. Its gel-based formulation ensures fast absorption, non-greasy application, and enhanced patient compliance, making it ideal for first-time retinoid users or maintenance therapy.

A-RET 0.01% Gel, Tretinoin topical gel USP, low-strength retinoid therapy, mild acne treatment, skin renewal gel, early photoaging management, dermatology gel, pharmaceutical exporter India, and skincare manufacturer India.

A-RET 0.01% Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin health programs, and international pharmaceutical distributors.

Adene Gel
Composition: Adapalene 0.1% w/w
International Trade Name: Adene Gel

Adene Gel is a high-quality topical retinoid gel containing Adapalene 0.1%, designed for the effective management of acne vulgaris. Manufactured in WHO-GMP certified facilities, Adene Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Adapalene is a synthetic retinoid that works by normalizing follicular epithelial cell turnover, preventing comedone formation, and reducing inflammation, thereby improving both inflammatory and non-inflammatory acne lesions. Adene Gel promotes skin renewal and helps in the prevention of future breakouts, providing a long-term solution for acne management.

Adene Gel is primarily indicated for the topical treatment of mild to moderate acne vulgaris, including papules, pustules, and comedones. Its gel-based formulation ensures rapid absorption, non-greasy application, and enhanced patient compliance.

Adene Gel, Adapalene topical gel, anti-acne retinoid therapy, comedone prevention gel, inflammatory and non-inflammatory acne treatment, pharmaceutical exporter India, and dermatology manufacturer India.

Adene Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Acnon Gel 0.05%
Composition: Tretinoin 0.05% w/w (USP Grade)
International Trade Name: Acnon Gel

Acnon Gel 0.05% is a high-quality topical retinoid formulation containing Tretinoin 0.05% USP, designed for the effective management of acne vulgaris and photoaged skin. Manufactured in WHO-GMP certified facilities, Acnon Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial cell turnover, preventing comedone formation, and promoting skin renewal. Acnon Gel 0.05% helps reduce inflammatory and non-inflammatory acne lesions, improves skin texture, and minimizes fine lines, hyperpigmentation, and sun-induced skin damage.

Acnon Gel 0.05% is primarily indicated for the topical treatment of mild to moderate acne vulgaris, especially in patients requiring advanced retinoid therapy. It can also be used as part of dermatological regimens for photoaging, skin rejuvenation, and hyperpigmentation management. Its gel-based formulation ensures fast absorption, non-greasy application, and enhanced patient compliance.

Acnon Gel 0.05%, Tretinoin USP topical gel, anti-acne retinoid therapy, skin renewal gel, photoaging and hyperpigmentation management, dermatology gel, pharmaceutical exporter India, and skincare manufacturer India.

Acnon Gel 0.05% is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin health programs, and international pharmaceutical distributors.

Placentrex Gel
Composition: Placenta Extracts Gel IP
International Trade Name: Placentrex® (Topical Regenerative & Healing Gel)

Placentrex Gel is a high-quality topical formulation containing human placental extracts, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, Placentrex Gel is designed for skin regeneration, wound healing, and repair of damaged tissues, supporting dermatology, cosmetic, and therapeutic treatment programs worldwide.

Placenta extracts are rich in bioactive proteins, amino acids, growth factors, and vitamins, which promote tissue repair, enhance collagen synthesis, and stimulate cellular regeneration. The gel formulation ensures easy application, rapid absorption, and localized therapeutic action, making it highly effective for both clinical and home use.

Placentrex Gel is primarily indicated for the management of chronic wounds, burns, surgical incisions, ulcers, and skin damage due to trauma or aging. It is suitable for use in dermatology clinics, hospitals, plastic surgery centers, and home care under medical supervision.

Placentrex Gel, Placenta Extract topical gel, wound healing and skin regeneration gel, post-surgical scar repair, chronic ulcer therapy, dermatology exporter India, and pharmaceutical manufacturer India.

Placentrex Gel is manufactured under strict GMP and quality assurance standards, ensuring consistent efficacy, safety, and product stability. The gel is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Tretiron 0.05% Cream
Composition: Tretinoin 0.05% w/w
International Trade Name: Tretiron

Tretiron 0.05% Cream is a high-quality topical retinoid formulation containing Tretinoin 0.05%, designed for the effective management of acne vulgaris and early signs of photoaging. Manufactured in WHO-GMP certified facilities, Tretiron Cream is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Tretinoin, a vitamin A derivative (all-trans retinoic acid), works by normalizing follicular epithelial cell turnover, preventing comedone formation, and promoting skin renewal. Tretiron 0.05% Cream helps reduce inflammatory and non-inflammatory acne lesions, improve skin texture, and minimize fine lines, hyperpigmentation, and sun-induced skin damage.

Tretiron 0.05% Cream is primarily indicated for the topical treatment of mild to moderate acne vulgaris, as well as in dermatological regimens for skin rejuvenation, photoaging, and pigmentation management. Its cream formulation ensures smooth application, better skin penetration, and enhanced patient compliance.

Tretiron 0.05% Cream, Tretinoin topical cream, anti-acne retinoid therapy, skin renewal cream, photoaging treatment, dermatology cream, pharmaceutical exporter India, and dermatology manufacturer India.

Tretiron 0.05% Cream is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

Resoten-20 Capsules
Composition: Isotretinoin 20 mg
International Trade Name: Resoten-20

Resoten-20 Capsules are a high-quality oral retinoid formulation containing Isotretinoin 20 mg, designed for the effective management of severe and treatment-resistant acne vulgaris. Manufactured in WHO-GMP certified facilities, Resoten-20 is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Isotretinoin is a vitamin A derivative that works by reducing sebaceous gland activity, normalizing follicular epithelial cell turnover, and providing anti-inflammatory effects, resulting in long-term reduction of acne lesions, prevention of scarring, and reduced recurrence. Resoten-20 Capsules provide precise oral dosing, allowing dermatologists to tailor therapy according to patient severity and response.

Resoten-20 Capsules are primarily indicated for the treatment of severe, nodulocystic, or recalcitrant acne vulgaris, especially in patients who have not responded to conventional topical and systemic therapies. The capsules are formulated for high bioavailability, consistent dosing, and improved patient compliance.

Resoten-20, Isotretinoin oral capsules, severe acne therapy, anti-seborrheic retinoid, dermatology oral treatment, pharmaceutical exporter India, and dermatology manufacturer India.

Resoten-20 Capsules are produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Tecum 0.1% Ointment
Composition: Tacrolimus 0.1% w/w
International Trade Name: Tecum

Tecum 0.1% Ointment is a high-quality topical immunomodulator containing Tacrolimus 0.1%, designed for the effective management of inflammatory skin disorders, particularly atopic dermatitis. Manufactured in WHO-GMP certified facilities, Tecum Ointment is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Tacrolimus is a calcineurin inhibitor that works by suppressing T-cell activation and the release of inflammatory cytokines, thereby reducing inflammation, redness, and itching without the adverse effects associated with long-term corticosteroid use. Tecum 0.1% Ointment provides targeted relief for moderate to severe dermatological conditions, especially in sensitive areas such as the face, neck, and flexural regions.

Tecum 0.1% Ointment is primarily indicated for the topical treatment of moderate to severe atopic dermatitis, as well as other corticosteroid-responsive inflammatory dermatoses where long-term corticosteroid therapy is not advisable. Its ointment formulation ensures excellent skin penetration, sustained effect, and enhanced patient compliance.

Tecum 0.1% Ointment, Tacrolimus topical ointment, calcineurin inhibitor therapy, anti-inflammatory dermatology ointment, atopic dermatitis management, pharmaceutical exporter India, and dermatology manufacturer India.

Tecum 0.1% Ointment is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

TECUM 0.03% Ointment
Composition: Tacrolimus 0.03% w/w
International Trade Name: TECUM

TECUM 0.03% Ointment is a high-quality topical immunomodulatory formulation containing Tacrolimus 0.03%, designed for the management of mild to moderate atopic dermatitis and other corticosteroid-responsive dermatological conditions. Manufactured in WHO-GMP certified facilities, TECUM Ointment is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Tacrolimus is a calcineurin inhibitor that works by suppressing T-cell activation and inhibiting pro-inflammatory cytokine release, effectively reducing inflammation, redness, and itching associated with chronic skin disorders. TECUM 0.03% Ointment provides a non-greasy, smooth formulation, allowing rapid absorption and targeted action, while avoiding the side effects associated with long-term corticosteroid use.

TECUM 0.03% Ointment is primarily indicated for the topical treatment of mild to moderate atopic dermatitis in children and adults, especially in areas where long-term corticosteroid therapy is undesirable or inadequate. It may also be used for other immune-mediated dermatological conditions under specialist supervision.

TECUM Ointment, Tacrolimus 0.03% topical ointment, immunomodulatory dermatology therapy, anti-inflammatory skin treatment, atopic dermatitis management, pharmaceutical exporter India, and dermatology manufacturer India.

TECUM 0.03% Ointment is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

Benzac AC Gel
Composition: Benzoyl Peroxide 5% w/w
International Trade Name: Benzac AC

Benzac AC Gel is a high-quality topical anti-acne formulation containing 5% Benzoyl Peroxide, designed for the effective management of mild to moderate acne vulgaris. Manufactured in WHO-GMP certified facilities, Benzac AC Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Benzoyl Peroxide works by reducing Propionibacterium acnes (Cutibacterium acnes) colonization, unclogging pores, and preventing comedone formation. Its keratolytic action promotes skin exfoliation, reducing acne lesions and preventing new breakouts. Benzac AC Gel provides a non-greasy, easily absorbable formulation, ensuring convenient application and enhanced patient compliance.

Benzac AC Gel is primarily indicated for the topical treatment of mild to moderate inflammatory and non-inflammatory acne vulgaris, including papules, pustules, and comedones. It can also be used as part of combination therapy with other acne treatments for enhanced clinical outcomes.

Benzac AC Gel, Benzoyl Peroxide topical gel, anti-acne therapy, keratolytic acne treatment, dermatology gel, pharmaceutical exporter India, and dermatological product manufacturer India.

Benzac AC Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Loceryl Cream
Composition: Amorolfine Cream IP
International Trade Name: Loceryl® (Topical Antifungal)

Loceryl Cream is a high-quality topical antifungal formulation containing Amorolfine, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, Loceryl Cream is designed for effective management of superficial fungal infections, supporting dermatology treatment programs globally.

Amorolfine is a broad-spectrum antifungal agent that works by inhibiting ergosterol synthesis in fungal cell membranes, leading to fungal cell death. The cream formulation ensures rapid skin penetration, localized action, and convenient application, providing effective relief from fungal infections with minimal systemic exposure.

Loceryl Cream is primarily indicated for the topical treatment of dermatophytic infections, candidiasis, and other superficial fungal skin infections. It is suitable for use in dermatology clinics, hospitals, and home care, offering safe and effective therapy under medical supervision.

Loceryl Cream, Amorolfine topical cream, antifungal dermatology cream, superficial fungal infection treatment, dermatophyte and yeast infection management, dermatology exporter India, and pharmaceutical manufacturer India.

Loceryl Cream is manufactured under strict GMP and quality assurance standards, ensuring consistent efficacy, safety, and product stability. The cream is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Benzac AC Gel
Composition: Benzoyl Peroxide 5% w/w
International Trade Name: Benzac AC

Benzac AC Gel is a high-quality topical anti-acne formulation containing 5% Benzoyl Peroxide, designed for the effective management of mild to moderate acne vulgaris. Manufactured in WHO-GMP certified facilities, Benzac AC Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Benzoyl Peroxide works by reducing Cutibacterium acnes colonization, unclogging pores, and promoting exfoliation of dead skin cells, thereby preventing comedone formation and controlling acne flare-ups. The gel formulation ensures rapid absorption, non-greasy application, and convenient daily usage, enhancing patient compliance.

Benzac AC Gel is primarily indicated for the topical treatment of mild to moderate inflammatory and non-inflammatory acne, including papules, pustules, and comedones. It can also be used as part of combination therapy with other anti-acne agents for enhanced results.

Benzac AC Gel, Benzoyl Peroxide topical gel, anti-acne therapy, keratolytic acne treatment, dermatology gel, pharmaceutical exporter India, and dermatology manufacturer India.

Benzac AC Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Kojiglo Gold Cream
Composition: Kojic Acid 2% w/w + Other Skin Brightening Agents (as per formulation)
International Trade Name: Kojiglo Gold

Kojiglo Gold Cream is a high-quality topical skin lightening formulation containing Kojic Acid, designed for the effective management of hyperpigmentation, dark spots, and uneven skin tone. Manufactured in WHO-GMP certified facilities, Kojiglo Gold Cream is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological and cosmetic treatment programs globally.

Kojic Acid works by inhibiting tyrosinase activity, thereby reducing melanin production and promoting a brighter, more even skin tone. Kojiglo Gold Cream’s formulation also helps lighten freckles, age spots, melasma, and post-inflammatory hyperpigmentation, giving skin a healthy and radiant appearance.

Kojiglo Gold Cream is primarily indicated for the topical treatment of hyperpigmentation disorders, melasma, sun-induced dark spots, and uneven skin tone. Its cream-based formulation ensures smooth application, rapid absorption, and excellent skin compatibility.

Kojiglo Gold Cream, Kojic Acid skin lightening cream, hyperpigmentation therapy, dark spot reduction, melasma management, dermatology and cosmetic cream, pharmaceutical exporter India, and skincare manufacturer India.

Kojiglo Gold Cream is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, cosmetic centers, hospitals, pharmacies, government skin care programs, and international distributors.

Doxizen LB Tablets
Composition: Doxycycline & Lactic Acid Bacillus Tablets
International Trade Name: Doxizen LB®

Doxizen LB is a high-quality combination tablet containing Doxycycline, a broad-spectrum antibiotic, and Lactic Acid Bacillus, a probiotic, designed for the effective management of bacterial infections while supporting gastrointestinal health. Manufactured in WHO-GMP certified facilities, Doxizen LB Tablets are supplied by trusted pharmaceutical exporters from India to support global healthcare treatment programs.

Doxycycline works by inhibiting bacterial protein synthesis, effectively treating a wide range of Gram-positive and Gram-negative bacterial infections. Lactic Acid Bacillus helps restore and maintain the natural balance of intestinal microflora, reducing the risk of antibiotic-associated diarrhea and other gastrointestinal disturbances.

Doxizen LB Tablets are primarily indicated for the treatment of respiratory tract infections, urinary tract infections, gastrointestinal infections, and other bacterial infections where maintaining gut flora is important. They are suitable for adult and pediatric patients under medical supervision, particularly during prolonged antibiotic therapy.

Doxizen LB Doxycycline & Lactic Acid Bacillus Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, and international pharmaceutical distributors.

Clencin Gel
Composition: Clindamycin Phosphate 1% w/w (USP)
International Trade Name: Clencin Gel

Clencin Gel is a high-quality topical antibiotic formulation containing Clindamycin Phosphate USP 1%, designed for the effective management of acne vulgaris and other superficial bacterial skin infections. Manufactured in WHO-GMP certified facilities, Clencin Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Clindamycin Phosphate is a broad-spectrum antibiotic that works by inhibiting bacterial protein synthesis, effectively reducing Cutibacterium acnes (formerly Propionibacterium acnes) colonization and associated inflammation. Clencin Gel provides a fast-absorbing, non-greasy formulation, ensuring targeted antibacterial action and enhanced patient compliance.

Clencin Gel is primarily indicated for the topical treatment of mild to moderate inflammatory acne vulgaris, including papules, pustules, and comedones. It can also be used as part of combination therapy with retinoids or other anti-acne agents for optimized clinical outcomes.

Clencin Gel, Clindamycin Phosphate topical gel USP, anti-acne antibiotic therapy, inflammatory acne management, dermatology gel, pharmaceutical exporter India, and dermatology manufacturer India.

Clencin Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Kroty Cream
Composition: Crotamiton Cream IP
International Trade Name: Crotamiton (Topical Anti-Pruritic & Scabicidal)

Kroty Cream is a high-quality topical formulation containing Crotamiton, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, Kroty Cream is designed to provide effective relief from itching, scabies, and other pruritic skin conditions, supporting dermatological care programs globally.

Crotamiton works by inhibiting the activity of skin-surface mites and providing anti-pruritic action, helping to relieve itching, irritation, and discomfort. Its smooth cream formulation ensures easy application, rapid absorption, and localized therapeutic action, making it convenient for both clinical and home use.

Kroty Crotamiton Cream IP is primarily indicated for the treatment of scabies and relief of pruritus associated with dermatological conditions. It is suitable for adults and children (as per medical advice) and is widely used in dermatology clinics, hospitals, and home care.

Kroty Cream, Crotamiton topical cream, anti-itch cream, scabicidal treatment, pruritus management, dermatology exporter India, and pharmaceutical manufacturer India.

Kroty Crotamiton Cream IP is manufactured under strict GMP and quality assurance standards, ensuring consistent efficacy, safety, and product stability. The cream is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, pharmacies, hospitals, government health programs, and international pharmaceutical distributors.

Xerolene Max Cream
Composition: Propylene Glycol, Light Liquid Paraffin, Aloe Vera, Cetostearyl Alcohol
International Trade Name: Xerolene® Max (Moisturizing & Skin Protectant Cream)

Xerolene Max Cream is a high-quality topical emollient and moisturizer, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, Xerolene Max Cream is designed for intensive skin hydration, protection, and repair, supporting dermatology, skincare, and cosmetic treatment programs globally.

The formulation combines Propylene Glycol and Light Liquid Paraffin to provide long-lasting hydration and barrier protection, Aloe Vera for soothing, anti-inflammatory, and skin-healing effects, and Cetostearyl Alcohol for emulsifying and skin-conditioning action. This combination ensures rapid absorption, non-greasy feel, and effective skin restoration.

Xerolene Max Cream is primarily indicated for the management of dry, rough, or scaly skin, minor irritations, and compromised skin barrier conditions. It is suitable for use in dermatology clinics, hospitals, home care, and cosmetic skin therapy programs, and is ideal for patients of all ages.

Xerolene Max Cream, propylene glycol moisturizer, light liquid paraffin emollient, aloe vera skin repair cream, cetostearyl alcohol cream, dry skin management, dermatology exporter India, and pharmaceutical manufacturer India.

Xerolene Max Cream is manufactured under strict GMP and quality assurance standards, ensuring consistent efficacy, safety, and stability. The cream is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Trichosheen Cetrimide Lotion
Composition: Cetrimide 0.5% w/v (or as per standard formulation)
International Trade Name: Trichosheen

Trichosheen Cetrimide Lotion is a high-quality topical antiseptic formulation designed for effective skin cleansing, prevention of infection, and management of minor cuts, wounds, burns, and abrasions. Manufactured in WHO-GMP certified facilities, Trichosheen Lotion is supplied by trusted pharmaceutical manufacturers and exporters from India to support global dermatological and first-aid treatment programs.

Cetrimide is a quaternary ammonium compound with potent antibacterial and antiseptic properties, helping to cleanse wounds, prevent bacterial growth, and promote a healthy healing environment. Trichosheen Lotion provides a non-greasy, easily absorbable application, ensuring convenient usage and enhanced patient compliance.

Trichosheen Cetrimide Lotion is primarily indicated for the topical treatment of minor cuts, abrasions, burns, skin infections, and for pre- and post-surgical skin antisepsis. Its gentle yet effective formulation is suitable for daily skin cleansing and hygiene in both hospital and home settings.

Trichosheen Cetrimide Lotion, Cetrimide topical lotion, antibacterial skin cleanser, antiseptic lotion, minor wound care solution, dermatology and first-aid treatment, pharmaceutical exporter India, and topical antiseptic manufacturer India.

Trichosheen Cetrimide Lotion is manufactured under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Somicin Cream
Composition: Sisomicin Sulfate 1% w/w
International Trade Name: Somicin

Somicin Cream is a high-quality topical antibiotic formulation containing Sisomicin Sulfate 1%, designed for the effective management of bacterial skin infections. Manufactured in WHO-GMP certified facilities, Somicin Cream is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Sisomicin is an aminoglycoside antibiotic that works by inhibiting bacterial protein synthesis, effectively targeting Gram-positive and Gram-negative bacteria, including Staphylococcus aureus, Streptococcus pyogenes, and other common skin pathogens. This results in rapid clearance of infections, reduction of inflammation, and promotion of healing.

Somicin Cream is primarily indicated for the topical treatment of bacterial skin infections, including impetigo, infected cuts, abrasions, folliculitis, and minor wounds. Its cream formulation ensures excellent skin penetration, prolonged contact with affected areas, and ease of application.

Somicin Cream, Sisomicin Sulfate topical cream, antibacterial skin therapy, Gram-positive and Gram-negative infection treatment, dermatology cream, pharmaceutical exporter India, and dermatology manufacturer India.

Somicin Cream is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government skin care programs, and international pharmaceutical distributors.

Kojivit Ultra Gel
Composition: Octinoxate + Niacinamide + Glycolic Acid
Dosage Form: Topical Gel
International Trade Name: Kojivit Ultra

Kojivit Ultra Gel is a high-quality advanced dermatological formulation designed for the management of hyperpigmentation, uneven skin tone, and photo-induced skin damage. Manufactured in WHO-GMP certified facilities, Kojivit Ultra Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support global dermatology and cosmetic care programs.

Octinoxate acts as a UVB sunscreen agent, helping protect the skin from sun-induced pigmentation and photoaging. Niacinamide (Vitamin B3) supports skin barrier repair, reduces inflammation, and improves overall skin tone and texture, while Glycolic Acid, a well-known alpha hydroxy acid (AHA), promotes controlled exfoliation, enhanced skin renewal, and improved penetration of active ingredients. The combination provides a multifunctional approach to skin brightening and rejuvenation.

Kojivit Ultra Gel is primarily indicated for the topical management of melasma, dark spots, tanning, post-inflammatory hyperpigmentation, and uneven complexion. Its lightweight, non-greasy gel formulation ensures quick absorption, smooth spreadability, and excellent patient compliance, making it suitable for daily dermatological use under medical guidance.

Kojivit Ultra Gel, Octinoxate sunscreen gel, Niacinamide skin brightening gel, Glycolic Acid exfoliating gel, hyperpigmentation treatment, melasma management, dermatology cosmetic gel, pharmaceutical exporter India, and skincare manufacturer India.

Kojivit Ultra Gel is manufactured under stringent GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, cosmetic centers, hospitals, pharmacies, government skin care programs, and international distributors.

Momate S Ointment
Composition: Mometasone Furoate 0.1% w/w + Salicylic Acid 3% w/w
International Trade Name: Momate S

Momate S Ointment is a high-quality combination topical formulation containing Mometasone Furoate (a potent corticosteroid) and Salicylic Acid (a keratolytic agent), specifically designed for the management of inflammatory and hyperkeratotic skin conditions. Manufactured in WHO-GMP certified facilities, Momate S Ointment is supplied by trusted pharmaceutical manufacturers and exporters from India to meet global dermatological treatment requirements.

Mometasone Furoate reduces inflammation, redness, and itching by modulating the body’s immune response, while Salicylic Acid works by softening and removing excess keratin, helping to treat scaly and thickened skin lesions effectively. The combination ensures rapid symptomatic relief while promoting skin renewal.

Momate S Ointment is primarily indicated for the topical treatment of psoriasis, eczema, seborrheic dermatitis, hyperkeratotic lesions, and other corticosteroid-responsive dermatoses where keratolytic action is desired. Its smooth, ointment-based formulation ensures enhanced skin penetration, prolonged action, and patient compliance.

Momate S Ointment, Mometasone + Salicylic Acid ointment, anti-inflammatory keratolytic topical, corticosteroid combination therapy, psoriasis and eczema treatment, dermatology ointment exporter India, and pharmaceutical manufacturer India.

Momate S Ointment is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Noxin Gel
Composition: Nadifloxacin 1% w/w
International Trade Name: Noxin

Noxin Gel is a high-quality topical fluoroquinolone antibacterial formulation containing Nadifloxacin 1%, designed for the effective management of acne vulgaris and other superficial bacterial skin infections. Manufactured in WHO-GMP certified facilities, Noxin Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs globally.

Nadifloxacin is a broad-spectrum antibacterial agent that works by inhibiting bacterial DNA gyrase and topoisomerase IV, effectively reducing bacterial growth and inflammation. Noxin Gel provides rapid penetration into the affected areas, ensuring targeted antibacterial action and promoting faster healing of acne lesions.

Noxin Gel is primarily indicated for the topical treatment of mild to moderate inflammatory and non-inflammatory acne vulgaris, including papules, pustules, and comedones. Its gel-based formulation ensures non-greasy application, easy absorption, and enhanced patient compliance, making it suitable for daily dermatological use.

Noxin Gel, Nadifloxacin topical gel, anti-acne antibacterial therapy, fluoroquinolone dermatology gel, inflammatory and non-inflammatory acne treatment, pharmaceutical exporter India, and dermatology manufacturer India.

Noxin Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.

Noxin Cream
Composition: Nadifloxacin Cream IP
International Trade Name: Noxin® (Topical Fluoroquinolone Antibiotic)

Noxin Cream is a high-quality topical formulation containing Nadifloxacin, a broad-spectrum fluoroquinolone antibiotic, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, Noxin Cream is designed for effective management of bacterial skin infections and inflammatory acne, supporting dermatology treatment programs worldwide.

Nadifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and eliminating pathogenic microorganisms on the skin. The cream formulation ensures rapid absorption, targeted action, and convenient application, delivering effective antimicrobial therapy with minimal systemic exposure.

Noxin Cream is primarily indicated for the topical treatment of bacterial skin infections, including impetigo, folliculitis, and inflammatory acne vulgaris. It is suitable for use in dermatology clinics, hospitals, and home care under medical supervision.

Noxin Cream, Nadifloxacin topical cream, antibacterial dermatology cream, acne and skin infection therapy, fluoroquinolone antibiotic cream, dermatology exporter India, and pharmaceutical manufacturer India.

Noxin Cream is manufactured under strict GMP and quality assurance standards, ensuring consistent efficacy, safety, and product stability. The cream is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Sudif Cream
Composition: Fusidic Acid Cream IP / BP 2% w/w
Pack Size: 10 g
International Trade Name: Sudif® (Topical Antibiotic)

Sudif Cream is a high-quality topical antibiotic formulation containing Fusidic Acid, manufactured in WHO-GMP certified facilities. Supplied by trusted pharmaceutical exporters from India, Sudif Cream is designed for effective management of bacterial skin infections, supporting dermatology treatment programs globally.

Fusidic Acid is a narrow-spectrum antibiotic that works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and promoting rapid healing of infected skin. The cream formulation ensures localized action, rapid absorption, and convenient application, providing effective therapy with minimal systemic exposure.

Sudif Cream is primarily indicated for the topical treatment of skin infections caused by susceptible bacteria, including impetigo, infected eczema, minor wounds, burns, and post-surgical infections. It is suitable for use in dermatology clinics, hospitals, and home care under medical supervision.

Sudif Cream, Fusidic Acid topical cream, antibacterial dermatology cream, skin infection treatment, minor wound infection therapy, dermatology exporter India, and pharmaceutical manufacturer India.

Sudif Cream is manufactured under strict GMP and quality assurance standards, ensuring consistent efficacy, safety, and product stability. The cream is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

Acnon-C Gel
Composition: Clindamycin Phosphate 1% w/w + Tretinoin 0.025% w/w (or as per standard formulation)
International Trade Name: Acnon-C Gel

Acnon-C Gel is a high-quality combination topical gel containing Clindamycin Phosphate and Tretinoin, designed for the effective management of acne vulgaris. Manufactured in WHO-GMP certified facilities, Acnon-C Gel is supplied by trusted pharmaceutical manufacturers and exporters from India to support advanced dermatological treatment programs worldwide.

Clindamycin Phosphate is a topical antibiotic that works by reducing bacterial colonization, particularly Cutibacterium acnes, while Tretinoin, a vitamin A derivative, normalizes follicular epithelial cell turnover, prevents comedone formation, and promotes skin renewal. The combination provides a dual-action approach, targeting both inflammation and comedonal acne for faster and more effective results.

Acnon-C Gel is primarily indicated for the topical treatment of mild to moderate inflammatory and non-inflammatory acne vulgaris, including papules, pustules, and comedones. Its gel-based formulation ensures quick absorption, non-greasy application, and enhanced patient compliance.

Acnon-C Gel, Clindamycin + Tretinoin topical gel, dual-action anti-acne therapy, retinoid-antibiotic combination, inflammatory and non-inflammatory acne treatment, dermatology gel, pharmaceutical exporter India, and dermatology manufacturer India.

Acnon-C Gel is produced under strict GMP and quality control standards, ensuring consistent efficacy, safety, and stability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government acne management programs, and international pharmaceutical distributors.